2D-BioPAD at the 34TH Alzheimer Europe Conference
Our partner Evnia submitted an abstract and represented the consortium at the 34th Alzheimer Europe Conference in Geneva,...
Read more
Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease.
Learn moreIn a Nutshell
2D-BioPAD is pioneering a graphene-based Point-of-Care (PoC) In-Vitro Diagnostics (IVD) system for early Alzheimer’s Disease (AD) detection. This non-invasive solution, using 2D materials, can identify and quantify up to 5 AD biomarkers in real-time. Clinical pilot studies in Finland, Greece, and Germany aim to demonstrate its impact, with a focus on safety, ethics, and seamless integration into primary healthcare settings.
Latest News
Magnetic Nanoparticles for Biosensors
Materials in the nanoscale have unique properties that set them apart from regular materials, making them ideal for...
Read more
ICN2 showcases 2D-BioPAD at SENSE workshop
Our partners Marianna Rossetti and Ruslan Alvarez from ICN2 recently participated in the SENSE Workshop in San Sebastian,...
Read more
Improving biosensing quality with graphene derivatives
Graphene derivatives… different materials? Graphene has a rich chemistry leading to derivatives which are crucial for its application...
Read more
Consortium Partners
